Tower Research Capital (TRC)
FCSC

Tower Research Capital (TRC)’s Fibrocell Science Inc. FCSC Stock Holding History

Tower Research Capital (TRC)’s Portfolio FCSC Stock Details FCSC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-510
Closed -$8K – 4312
2017
Q3 		$8K Buy
510
+383
+302% +$6.19K ﹤0.01% 3181
2017
Q2 		$3K Sell
127
-263
-67% -$3.25K ﹤0.01% 2283
2017
Q1 		$4K Buy
390
+98
+34% +$1.09K ﹤0.01% 2396
2016
Q4 		$3K Sell
292
-677
-70% -$7.27K ﹤0.01% 3335
2016
Q3 		$10K Buy
969
+873
+909% +$12.9K ﹤0.01% 2094
2016
Q2 		$2K Buy
+96
New +$2.99K ﹤0.01% 4039
2015
Q1 		– Sell
-38
Closed -$1K – 5180
2014
Q4 		$1K Buy
+38
New +$1.54K ﹤0.01% 3802
2014
Q3 		– Sell
-106
Closed -$6K – 5112
2014
Q2 		$6K Sell
106
-184
-63% -$10.3K ﹤0.01% 2775
2014
Q1 		$23K Buy
290
+182
+169% +$14.1K ﹤0.01% 1765
2013
Q4 		$7K Buy
108
+10
+10% +$582 ﹤0.01% 3338
2013
Q3 		$6K Buy
98
+52
+113% +$4.2K ﹤0.01% 3593
2013
Q2 		$4K Buy
+46
New +$3.8K ﹤0.01% 3151

Other funds holding FCSC

Third Security
Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return
MSD Partners
MSD Partners New York $76.8M AUM 34.91% 1-Year Est. Return
Armistice Capital
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Anson Funds Management
Anson Funds Management Dallas, Texas $1.68B AUM 373.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FNY Partners Fund
FNY Partners Fund New York $185M AUM 32.65% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $45.2B AUM 20.72% 1-Year Est. Return

Tower Research Capital (TRC)'s FCSC Position: Q4 2017 in Review

Tower Research Capital (TRC) sold out of Fibrocell Science Inc. (FCSC) in Q4 2017, closing a stake of 510 shares — an estimated $8K sold.

Tower Research Capital (TRC) first reported a position in FCSC in Q2 2013 and held it in 12 quarters. The position peaked at $23K in Q1 2014. 32 funds tracked by Wall St. Rank hold FCSC as of Q4 2017.

  • Tower Research Capital (TRC) reported no remaining Fibrocell Science Inc. position as of Q4 2017 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 510 Fibrocell Science Inc. shares in Q4 2017, an estimated $8K.
  • Tower Research Capital (TRC) first reported a position in Fibrocell Science Inc. in Q2 2013 and held it in 12 quarters.
  • Tower Research Capital (TRC)'s Fibrocell Science Inc. position peaked at $23K in Q1 2014.
  • 32 funds tracked by Wall St. Rank held Fibrocell Science Inc. as of Q4 2017.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2017, filed 9 Feb 2018.